Key facts
- AMD plans an equity investment in PsiQuantum; the companies did not disclose the size of the planned investment.
- AMD will provide CPUs, GPUs, adaptive computing technology and software; PsiQuantum will contribute its silicon photonics platform.
- The companies said PsiQuantum's drug research technology already runs on AMD hardware and produces more accurate results than existing methods.
- The Commerce Department said in May it planned minority equity stakes in nine quantum companies under a $2 billion CHIPS Act investment, including $100 million with PsiQuantum.
AMD plans to make an equity investment in quantum computing company PsiQuantum as part of an expanded partnership to develop the infrastructure required for utility-scale quantum computers, the companies said on November 12, 2026. The companies did not disclose the size of AMD's planned equity investment.
Under the partnership, AMD will provide CPUs, GPUs, adaptive computing technology and software, while PsiQuantum will contribute its silicon photonics platform, which integrates traditional computing chip technologies with optical networking technologies that use pulses of light to transmit data. The two will co-design computing infrastructure for quantum systems and develop applications that combine quantum computing with high-performance computing and AI.
The companies said PsiQuantum's drug research technology is already running on AMD hardware and can produce more accurate results than existing methods. In a statement, the companies said: "The combination of PsiQuantum's workflow with AMD's GPU expertise running large-scale simulation has delivered initial breakthrough results in simulation of covalent inhibitors, a class of molecules relevant in drug discovery for oncology."
The deal comes as quantum computing attracts growing investor interest, with companies and governments seeking systems capable of solving scientific and commercial problems too complex for conventional computers. The Commerce Department had announced in May plans to take minority equity stakes in nine quantum computing companies as part of a $2 billion investment under the CHIPS Act, including a $100 million deal with PsiQuantum.